Evidence map›Paper›PMID 42628842›Full record

ArticleMolecular & cellular proteomics : MCP2026

Surface Proteomics of Cancer-Derived Extracellular Vesicles Reveals Universal Heat Shock Proteins and Cancer Signatures.

Leyla Ayse Erozenci, Fenna Feenstra, Sander R Piersma, Thang V Pham, Jianing Liu, Joke Wortel, Jan R T van Weering, Natasja Fj Dits, Guido Jenster, R Jeroen A van Moorselaar and 2 more

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Leyla Ayse ErozenciAmsterdam UMC location Vrije Universiteit Amsterdam, OncoProteomics Laboratory, Department of Medical Oncolgy, Amsterdam, The Netherlands; Cancer Center Amsterdam, Research Program, Amsterdam, The Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Urology, Amsterdam, The Netherlands.
Fenna FeenstraAmsterdam UMC location Vrije Universiteit Amsterdam, OncoProteomics Laboratory, Department of Medical Oncolgy, Amsterdam, The Netherlands.
Sander R PiersmaAmsterdam UMC location Vrije Universiteit Amsterdam, OncoProteomics Laboratory, Department of Medical Oncolgy, Amsterdam, The Netherlands; Cancer Center Amsterdam, Research Program, Amsterdam, The Netherlands.
Thang V PhamAmsterdam UMC location Vrije Universiteit Amsterdam, OncoProteomics Laboratory, Department of Medical Oncolgy, Amsterdam, The Netherlands; Cancer Center Amsterdam, Research Program, Amsterdam, The Netherlands.
Jianing LiuAmsterdam UMC location Vrije Universiteit Amsterdam, OncoProteomics Laboratory, Department of Medical Oncolgy, Amsterdam, The Netherlands; Cancer Center Amsterdam, Research Program, Amsterdam, The Netherlands.
Joke WortelAmsterdam UMC location Vrije Universiteit Amsterdam, Department of Human Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Jan R T van WeeringAmsterdam UMC location Vrije Universiteit Amsterdam, Department of Human Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Natasja Fj DitsErasmus MC, Department of Urology, Rotterdam, The Netherlands.
Guido JensterErasmus MC, Department of Urology, Rotterdam, The Netherlands.
R Jeroen A van MoorselaarCancer Center Amsterdam, Research Program, Amsterdam, The Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Urology, Amsterdam, The Netherlands.
Irene V BijnsdorpCancer Center Amsterdam, Research Program, Amsterdam, The Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Urology, Amsterdam, The Netherlands. Electronic address: iv.bijnsdorp@amsterdamumc.nl.
Connie R JimenezAmsterdam UMC location Vrije Universiteit Amsterdam, OncoProteomics Laboratory, Department of Medical Oncolgy, Amsterdam, The Netherlands; Cancer Center Amsterdam, Research Program, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EVs) secreted by cancer cells are a valuable source of noninvasive biomarkers, as they are released into biofluids and reflect the molecular makeup of their cells of origin. To enable direct capture and detection of cancer-derived EVs, detailed knowledge of their surface proteome is essential. Here, we combined mild enzymatic treatment with mass spectrometry to analyze outward-facing proteins of EVs across a panel of 18 cell lines. This approach identified 1094 EV-associated surface proteins, including 144 transmembrane proteins involved in cellular communication and transport. Peptide-level analyses revealed that nearly 50% of multi-pass transmembrane proteins, such as ATP1A1, displayed their intracellular domains on the external EV surface. Out of a core set of 112 EV surface proteins shared across all cancer types, we report a top list of 15 highly abundant EV-surface proteins including ATP1A1, heat shock proteins (HSP)A8 and HSP90AB1 and nuclear proteins linked to EV biogenesis and cancer progression. This comprehensive profiling of EV surface proteomes from diverse cancer types reveals a robust set of pan-cancer EV surface markers with potential for diagnostic analysis.

Indexed as

cancerextracellular vesicleLC-MS/MS proteomicspan-cancersurface proteins

Identifiers

PMID42628842
PMCPMC13634791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.